首页> Lung cancer (Amsterdam, Netherlands)> Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer.

Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Keiko,Ohgino

第一单位： Department of Pulmonary Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.

作者： Keiko,Ohgino ^[1] ; Kenzo,Soejima ^[2] ; Hiroyuki,Yasuda ^[1] ; Yuichiro,Hayashi ^[3] ; Junko,Hamamoto ^[1] ; Katsuhiko,Naoki ^[1] ; Daisuke,Arai ^[1] ; Kota,Ishioka ^[1] ; Takashi,Sato ^[1] ; Hideki,Terai ^[1] ; Shinnosuke,Ikemura ^[1] ; Satoshi,Yoda ^[1] ; Tetsuo,Tani ^[1] ; Aoi,Kuroda ^[1] ; Tomoko,Betsuyaku ^[1]

作者单位： Department of Pulmonary Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. ^[1] Department of Pulmonary Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. Electronic address: ksoejima@cpnet.med.keio.ac.jp. ^[2] Department of Pathology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. ^[3]

关键词 Adenocarcinoma Fibroblast growth factor 9 Immunohistochemistry Non-small cell lung cancer Prognosis Squamous cell carcinoma cDNA microarray